Reaction

Antineutrophil Cytoplasmic Antibody Positive reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 719 reports · 76 co-occurring drugs

As of the last recalculation, Antineutrophil Cytoplasmic Antibody Positive appears in 719 FAERS reports alongside 76 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 427.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dutasteride	103	427.8	433.3
Drs. Clotrimazole	100	290.8	293.3
Family Wellness Clotrimazole	100	290.8	293.3
Clotrimazole Topical	100	290.6	293.2
Clotrimazole	100	273.6	275.9
Ciclesonide	106	264.1	266.2
Cefuroxime	81	231.0	232.7
Cephalexin	103	160.6	161.4
Moxifloxacin	69	156.7	157.5
Moxifloxacin Hydrochloride	90	146.8	147.4
Insulin Glargine-Yfgn	93	141.3	141.9
Doxazosin Mesylate	117	111.8	112.2
Antacid	143	108.5	108.9
Doxazosin	91	107.6	108.0
Bisacodyl Suppositories	42	99.7	100.1
Biscodyl	42	98.8	99.1
Umeclidinium Bromide And Vilanterol Trifenatate	52	97.1	97.4
Candesartan	102	96.3	96.6
Tamsulosin Hydrochloride	62	96.2	96.5
Bisacodyl	43	94.0	94.3
Sennosides	81	88.3	88.5
Magnesium Oxide	107	86.8	87.0
Mepolizumab	123	86.2	86.5
Calcium Carbonate	151	82.1	82.3
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	94	75.4	75.6
Budesonide	125	74.1	74.3
Candesartan Cilexetil	57	68.1	68.2
Diltiazem Hydrochloride	73	67.9	68.0
Levofloxacin	116	66.2	66.3
Levofloxacin In 5% Dextrose	116	66.2	66.3
Azithromycin	81	65.5	65.7
Azithromycin Monohydrate	81	63.3	63.4
Liraglutide	93	62.4	62.6
Salmeterol Xinafoate	18	62.0	62.1
Diltiazem Hydrochloride Extended-Release Tablets	23	60.4	60.5
Senna Leaf	45	60.2	60.3
Thiamine Hydrochloride	24	57.7	57.8
Azithromycin Dihydrate	94	53.2	53.3
Daspone	17	51.7	51.8
Dapsone Gel, 5%	17	51.7	51.8
Azathioprine	128	50.9	51.0
Fluticasone Propionate And Salmeterol Xinafoate	92	50.7	50.8
Trimethoprim	20	50.5	50.6
Escitalopram Oxalate	105	48.6	48.7
Dapsone	17	47.2	47.3
Fluticasone Furoate And Vilanterol Trifenatate	53	46.0	46.0
Escitslopram	78	43.4	43.5
Albuterol	144	43.2	43.2
Alendronate Sodium	113	38.3	38.3
Sulfamethoxazole And Trimethoprim	96	37.9	37.9
Methimazole	10	37.4	37.4
Montelukast	92	36.2	36.3
Pantoprazole Sodium In 0.9% Sodium Chloride	70	36.1	36.1
Pantoprazole Sodium Injection	70	36.1	36.1
Insulin Aspart	74	36.0	36.1
Senna	24	34.1	34.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	24	33.6	33.6
Sennosides 8.6 Mg Tablets	23	32.8	32.8
Hydroxyurea	23	32.5	32.5
Mometasone	19	30.8	30.8
Alendronate Sodium Tablet	18	28.8	28.8
Rosuvastatin Calcium	27	28.8	28.8
Amoxicillin And Clavulanate Potassium	26	28.7	28.7
Minocycline	11	27.7	27.7
Levothyroxine Sodium Anhydrous	80	25.9	25.9
Escitalopram	105	25.2	25.2
Tiotropium Bromide	102	25.0	25.0
Metformin Hydrochloride Tablets	46	24.7	24.8
Metformin Hydrochloride Extended-Release Tablets	46	24.7	24.8
Metformin Hydrochloride Tablet	46	24.7	24.8
Apixaban	52	24.2	24.2
Metformin Hydrochloride	46	24.0	24.0
Montelukast Sodium	84	22.5	22.5
Pioglitazone	21	14.5	14.5
Insulin Glargine	98	13.2	13.2
Copper	3	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.